PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3402040-1	1988	The present study was designed to compare the skin tumor promoting and epidermal ornithine decarboxylase (ODC) inducing activities of various structural analogs of anthralin (1,8-dihydroxy-9-anthrone) and chrysarobin (1,8-dihydroxy-3-methyl-9-anthrone).	Anthralin	164-173	ornithine decarboxylase, structural 1	Mus musculus	106-109	
3402040-12	1988	The ability of C10-substituted derivatives of anthralin to undergo base catalyzed oxidation in vitro correlated with both ODC inducing and tumor promoting activities.	Anthralin	46-55	ornithine decarboxylase, structural 1	Mus musculus	122-125	
7448761-0	1981	Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.	Anthralin	22-31	ornithine decarboxylase, structural 1	Mus musculus	96-119	
3677072-0	1987	Inhibition by retinoids of anthralin-induced mouse epidermal ornithine decarboxylase activity and anthralin-promoted skin tumor formation.	Anthralin	27-36	ornithine decarboxylase, structural 1	Mus musculus	61-84	
3677072-5	1987	Comparison of the doses of retinoids required to inhibit anthralin-induced ornithine decarboxylase by 50% and those required to inhibit anthralin-induced tumor promotion by 50% demonstrated that these values correlated.	Anthralin	57-66	ornithine decarboxylase, structural 1	Mus musculus	75-98